Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy vs Chemo + RT for CNS Germinoma
NCT00085098Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Jan 2007
- Primary completion
- May 2009
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial of carboplatin, etoposide, Cisplatin micelle injection (HA132) and cyclophosphamide in germinoma (2 arms), sponsored by Children's Oncology Group. Primary endpoints: Event-free Survival at 3 years and Overall Survival at 3 years. Started Jan 2007; status: completed.
02
Drugs
carboplatinetoposideCisplatin micelle injection (HA132)cyclophosphamide
03
Conditions
germinoma
Beyond the preview
Go deeper on NCT00085098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085098.